Capkan, D. U., & Solakhan, M. (2026). Diagnostic and Clinical Impact of Imaging Modality on PSA Density: TRUS Versus MRI in Gray-Zone Prostate Cancer. Current Oncology, 33(4), 221. https://doi.org/10.3390/curroncol33040221
Chicago Style (17th ed.) CitationCapkan, Davut Unsal, and Mehmet Solakhan. "Diagnostic and Clinical Impact of Imaging Modality on PSA Density: TRUS Versus MRI in Gray-Zone Prostate Cancer." Current Oncology 33, no. 4 (2026): 221. https://doi.org/10.3390/curroncol33040221.
MLA (9th ed.) CitationCapkan, Davut Unsal, and Mehmet Solakhan. "Diagnostic and Clinical Impact of Imaging Modality on PSA Density: TRUS Versus MRI in Gray-Zone Prostate Cancer." Current Oncology, vol. 33, no. 4, 2026, p. 221, https://doi.org/10.3390/curroncol33040221.